Centrum Terapii Wspolczesnej _J.M. Jasnorzewska Sp. Komandytowo-Akcyjna

Lodz 90-242

0 studies enrolling now · 8 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chronic Plaque Psoriasis, First Line Non-Small Cell Lung Cancer, Gastric Adenocarcinoma, Gastric, or Gastroesophageal Junction Adenocarcinoma, Metastatic Nonsquamous Non-Small Cell Lung Cancer, Metastatic Squamous Non-Small Cell Lung Cancer, Moderate to Severe Plaque Psoriasis, Plaque Type Psoriasis, Psoriasis, Rheumatoid Arthritis

Studies at this site

• Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer — Completed
• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma — Stopped early
• MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed
• Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis — Completed